The present invention provides flutamide, having a range of certain particle sizes and specific surface area, and methods for preparing such flutamide which are useful for preparing pharmaceutical formulations for the treatment of prostatic carcinoma and benign prostatic hypertrophy. The present invention further provides such compositions and methods of treating such disease states.
